Avalo Therapeutics, Inc. Common Stock
$15.47
▼ 0.25
(-1.59%)
Volume: 1,433,836
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
13
- 21d momentum -24.7%
- MA aligned bearish
- RSI 35
🎯
Pullback
62
- RSI 35 near lows
- Near lower Bollinger band
- -11.1% vs 20MA
💎
Value
58
- -36% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)34.7
MACD-0.183
MA trendBearish
ATR6.65%
21d mom.-24.7%
63d mom.-15.0%
vs 20MA-11.1%
RVOL(20)1.31×
52w low · 12
52w high · 24
-36.3% from 52-week high
20d support 15
· resistance 20
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$843M
PER—
PBR1.88
PSR14289.21
EPS$-1.87
ROE-22.4%
ROA-20.4%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA-8.30
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| -6.64% | -24.72% | -15.00% | +10.90% | +33.36% | -9.11% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -19.55%, daily vol 3.28%. Avalo Therapeutics, Inc. Common Stock sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.